The Link Between Varicella Zoster Virus and Dementia: A Comprehensive Review

Recent research has focused on the potential link between varicella zoster virus (VZV) and dementia, particularly Alzheimer’s disease. A systematic review and meta-analysis of observational studies suggest that VZV may play a significant role in the development of dementia, highlighting the need for further investigation into the viral hypothesis surrounding neurodegenerative diseases.

Nature

Varicella zoster virus, known for causing chickenpox and shingles, has been implicated in various neurological conditions. Studies have shown that reactivation of VZV can lead to complications such as vasculopathies, which may contribute to cognitive decline. The viral hypothesis posits that herpesviruses, including VZV, could be involved in the pathogenesis of Alzheimer’s disease through mechanisms such as neuroinflammation and neuronal damage.

Nature

Numerous researchers have contributed to the understanding of VZV's role in dementia. Notable studies include those by Wainberg et al. (2021), which discuss the viral hypothesis in Alzheimer’s disease, and Thapa et al. (2024), who conducted a meta-analysis on the risk of dementia following herpes zoster infection. Additionally, the work of Itzhaki et al. (2016) explores the broader implications of microbes in Alzheimer’s disease.

Nature

Recent findings indicate that vaccination against herpes zoster may reduce the risk of developing dementia. For instance, studies by Lehrer and Rheinstein (2021) and Schnier et al. (2022) demonstrate a correlation between herpes zoster vaccination and lower dementia incidence. The recombinant zoster vaccine has been associated with a significant decrease in dementia risk among older adults, as reported by Taquet et al. (2024).

Nature

The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have acknowledged the importance of herpes zoster vaccination in preventing complications associated with VZV. The CDC emphasizes that vaccination can mitigate the risk of shingles and its potential neurological consequences, while the FDA has approved vaccines like Shingrix for broader use.

Nature

Despite the emerging evidence, some experts remain skeptical about the direct link between VZV and dementia. Critics argue that while associations exist, causation has not been definitively established. Concerns about confounding factors in observational studies also persist, as highlighted by Remschmidt et al. (2015), who discuss biases that may affect the interpretation of vaccine effectiveness in relation to dementia outcomes.

Nature

While many studies support the association between VZV and dementia, discrepancies exist regarding the strength of this link. For example, some research indicates a clear correlation, while others suggest that the relationship may be influenced by additional variables, such as age and comorbidities. Further longitudinal studies are needed to clarify these conflicting findings.

Nature

• “Herpes zoster vaccination reduces risk of dementia.” — Lehrer, S. & Rheinstein, P. H.

Nature

• “The recombinant shingles vaccine is associated with lower risk of dementia.” — Taquet, M. et al.

Nature

• “The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease.” — Wainberg, M. et al.

Nature

• “Potential involvement of varicella zoster virus in Alzheimer’s disease via reactivation of quiescent herpes simplex virus type 1.” — Cairns, D. M. et al.

Nature

Ongoing studies aim to explore the mechanisms by which VZV may influence neurodegenerative processes. Researchers are also investigating the long-term effects of herpes zoster vaccination on cognitive health, with the hope of establishing clearer guidelines for prevention strategies in at-risk populations.

Nature